Home›People›David Snyder
David Snyder

David Snyder

Director of the Board at BTB Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Aug 12, 2026·Suggest an edit

About David Snyder

David Snyder is a director of the board at BTB Therapeutics.

Experience

This experience comes from David Snyder's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Snyder in the role, so the role may have started earlier or lasted longer.

BTB Therapeutics, Inc. Current
Director of the Board
Chairman of the Board of Directors (2026 – Present)
2025 – Present · Escondido, CA
Develops non-opioid pain medicines and treatments for rare genetic diseases and cancer.
The San Diego Symphony Orchestra Association Current
Chair Of The Board Of Directors
2023 – Present
PriceSmart Current
Vice Chairman & Lead Independent Director
2021 – Present
Pillsbury Winthrop Shaw Pittman LLP Current
Retired Partner
1993 – Present
University of San Diego School of Law
Adjunct Professor
2016 – 2025

Key Colleagues at Startups

The people David Snyder works with at each company, as listed on that company's latest Form D.

BTB Therapeutics, Inc. · Form D/A, Aug 12, 2026
Takashi Kiyoizumi
Takashi Kiyoizumi
CEO, Director of the Board
Masatoshi Hagiwara
Masatoshi Hagiwara
Chief Scientific Officer, Director of the Board
Nobuhiro Yagi
Nobuhiro Yagi
Director of the Board
SY
Sidney Yee
Director

Sources

  1. SECBTB Therapeutics, Inc. Form D/A, filed Aug 12, 2026